Article
Cardiac dysfunction in hypertrophic cardiomyopathy mutant tropomyosin mice is transgene-dependent, hypertrophy-independent, and improved by beta-blockade.
Circulation research - 9 Aug 2002
Michele Daniel E, Gomez Carlen A, Hong Katie E, Westfall Margaret V, Metzger Joseph M
Abstract excerpt
Familial hypertrophic cardiomyopathy (FHC) has been linked to mutations in proteins of the cardiac contractile apparatus, including alpha-tropomyosin (Tm). Mice expressing alphaTm in the heart were developed to determine the effects of FHC mutant Tm on cardiac structure and function from single cardiac myocytes to whole organ function in vivo. Expression of E180G mutant Tm did not produce cardiac hypertrophy or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
